Biotechnological applications of recombinant single-domain antibody fragments.
about
Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applicationsDirected Evolution of a Highly Specific FN3 Monobody to the SH3 Domain of Human Lyn Tyrosine Kinase.Functional production of a soluble and secreted single-chain antibody by a bacterial secretion systemGeneration of recombinant single-chain antibodies neutralizing the cytolytic activity of vaginolysin, the main virulence factor of Gardnerella vaginalis.Engineering venom's toxin-neutralizing antibody fragments and its therapeutic potential.Llama-derived single domain antibodies specific for Abrus agglutinin.Methodologies for the isolation of alternative binders with improved clinical potentiality over conventional antibodies.Combining magnetic nanoparticle with biotinylated nanobodies for rapid and sensitive detection of influenza H3N2.Strategies to stabilize compact folding and minimize aggregation of antibody-based fragmentsIsolation and epitope mapping of staphylococcal enterotoxin B single-domain antibodies.Linking Single Domain Antibodies that Recognize Different Epitopes on the Same Target.Progress in the development of immunoanalytical methods incorporating recombinant antibodies to small molecular weight biotoxins.Streamlining the Pipeline for Generation of Recombinant Affinity Reagents by Integrating the Affinity Maturation Step.Enhanced production of a single domain antibody with an engineered stabilizing extra disulfide bondNext-Generation Sequencing of a Single Domain Antibody Repertoire Reveals Quality of Phage Display Selected Candidates.Efficient method to optimize antibodies using avian leukosis virus display and eukaryotic cellsHigh-yield production of functional soluble single-domain antibodies in the cytoplasm of Escherichia coli.Trends in recombinant protein use in animal production.Immunoglobulin domains in Escherichia coli and other enterobacteria: from pathogenesis to applications in antibody technologies.New advances in molecular recognition based on biomolecular scaffolds.Microbials for the production of monoclonal antibodies and antibody fragments.Research applications of proteolytic enzymes in molecular biology.Fungal Glucosylceramide-Specific Camelid Single Domain Antibodies Are Characterized by Broad Spectrum Antifungal Activity.Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody.Construction of human anti-tetanus single-chain variable fragment applying SYMPLEX technology.Camelid Single-Domain Antibodies As an Alternative to Overcome Challenges Related to the Prevention, Detection, and Control of Neglected Tropical Diseases.Analysis of the binding loops configuration and surface adaptation of different crystallized single-domain antibodies in response to various antigens.Production in yeast of pseudotype virus-like particles harboring functionally active antibody fragments neutralizing the cytolytic activity of vaginolysin.A novel single-chain Fv antibody for connective tissue growth factor against the differentiation of fibroblast into myofibroblast.Site-specific fab fragment biotinylation at the conserved nucleotide binding site for enhanced Ebola detection.Can template-based protein models guide the design of sequence fitness for enhanced thermal stability of single domain antibodies?Efficient expression of single chain variable fragment antibody against paclitaxel using the Bombyx mori nucleopolyhedrovirus bacmid DNA system and its characterizations.Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview.Conjugation of biotin-coated luminescent quantum dots with single domain antibody-rhizavidin fusions.Molecular dynamics simulation of the crystallizable fragment of IgG1-insights for the design of FcabsEndogenous DKK1 and FRZB Regulate Chondrogenesis and Hypertrophy in Three-Dimensional Cultures of Human Chondrocytes and Human Mesenchymal Stem Cells.Improving the biophysical properties of anti-ricin single-domain antibodies.Multivalent dendritic molecules as broad spectrum bacteria agglutination agents.Functional mutations in and characterization of VHH against Helicobacter pylori urease.Engineered cross-reacting nanobodies simplify comparative oncology between humans and dogs.
P2860
Q26738678-D3E910B4-662A-452B-BD59-0E359F65DB7CQ30009044-4EDFC8F5-2A37-41C3-9398-9595048AD1DEQ33604858-056B80E1-6210-4F8E-876C-9C831E3FC808Q34065076-A6878018-B18F-4AF8-88E6-B77562B5722BQ34101828-15171DF8-994C-4A35-8270-C38A7D47DFDAQ34103619-E05ACE6B-F57A-4D60-8559-E5400C44BD0DQ34220190-39E4D6AE-4449-4DF8-B419-C4FFDA9CF8C7Q34352554-7EEDAD47-6736-4A3E-83BD-EDCBB1918FC0Q35018813-074A7B8F-4E5D-4082-BA9D-0B7D428A6D42Q35192027-A495DD74-3CD2-48B1-9191-400F7CA3D1D9Q35542285-3F54A4CA-6A12-45A7-8432-0E42323161B4Q35567882-281CBFFB-933D-4E1A-9784-9EF483EC6F0CQ35799445-23BF1A5B-587E-4875-A47B-529AF1BB48E3Q35800979-74D6EF25-A6DF-4313-8373-5A4AD4CAFC87Q35928753-B1D1EDC7-FEDB-473D-B840-2E10EA268009Q35961264-ACC052B1-F47B-42D0-921E-1C41CBCE51D2Q37283860-00089F66-FFF7-41EF-8A74-3265E36A38FBQ37680197-CEDCF4D8-C62B-4567-903D-F14ACF307412Q38020872-2282842E-EFAF-4713-A714-96AA88D760FAQ38105260-2B901EBC-E26D-4C4A-8133-76FAB4F5A1F7Q38159015-028F9065-2EC0-4CEE-A0A3-B888EBB4AFC2Q38223683-8B64D6EE-E5BE-4C98-A41D-25D31090B323Q38703594-9362C6C3-FF36-4D00-AAA3-D2322FF2CACFQ38728528-AC6CCC59-45A5-412B-99E3-988CC8AE9603Q38735637-94E6EB02-8610-4C33-BA35-D292622057EFQ39002539-A8534111-8A8F-47F7-BFB0-1C0F28DAEFC2Q39174984-53B51259-A115-4C9E-89FC-3427860A7A28Q39428042-3F685FDC-8FA4-44AE-8B5F-521FF2CACBEDQ39429905-671FC461-00CC-4478-9D1B-8C749EDD1957Q40169570-BABDFEAA-BD22-461D-BD4B-DD6EEAAC7F3EQ40535126-ABF4EA37-42C8-4EF0-AF0D-EB1A378B8239Q40873211-C8135FA9-ED61-4DC3-BA82-EF43E410757AQ41108385-D8CD215E-E6EA-418C-A787-D4083A4A2D4DQ41212173-245DF773-9EFE-447E-9101-7204AC2AB2B4Q41778455-A4168785-7D33-42AB-A700-D53DD456DA13Q41984107-B801B19A-F813-47C8-BB34-4CA83D2F3724Q42210192-B368846C-DCF5-4430-9119-03D5921BBD7FQ42631561-1A04B620-7512-436E-8DB4-E3606A4136D7Q45265906-0FD507D0-141D-441C-B118-CBC94250D7D9Q46280771-CADB6DEB-5C7C-4224-ADF7-E015CB377C88
P2860
Biotechnological applications of recombinant single-domain antibody fragments.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biotechnological applications of recombinant single-domain antibody fragments.
@en
Biotechnological applications of recombinant single-domain antibody fragments.
@nl
type
label
Biotechnological applications of recombinant single-domain antibody fragments.
@en
Biotechnological applications of recombinant single-domain antibody fragments.
@nl
prefLabel
Biotechnological applications of recombinant single-domain antibody fragments.
@en
Biotechnological applications of recombinant single-domain antibody fragments.
@nl
P2860
P921
P356
P1476
Biotechnological applications of recombinant single-domain antibody fragments.
@en
P2093
Ario de Marco
P2860
P2888
P356
10.1186/1475-2859-10-44
P577
2011-06-09T00:00:00Z
P5875
P6179
1012390222